发明名称 |
Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof |
摘要 |
The present application relates to isolated proteins, particularly monoclonal antibodies, in particular CDR-grafted, humanized antibodies which bind to RAGE protein. Specifically, these antibodies have the ability to inhibit the binding of RAGE to its various ligands. The antibodies or portions thereof of described in the present application are useful for treating a disease or disorder characterized by or induced by pathophysiological ligands of RAGE, for example missfolded proteins like amyloid β and advanced glycation-end-products. |
申请公布号 |
US9394363(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201213685899 |
申请日期 |
2012.11.27 |
申请人 |
ABBVIE DEUTSCHLAND GMBH & CO. KG;ABBVIE INC. |
发明人 |
Gu Jijie;Hsieh Chung-Ming;Wu Zhen;DiGiammarino Enrico L.;Luo Feng;Fox Gerard B.;Harlan John E.;Schmidt Martin;Loebbert Ralf;Mueller Reinhold;Ebert Ulrich;Nimmrich Volker |
分类号 |
C07K16/28;A61K39/395;A61K39/00 |
主分类号 |
C07K16/28 |
代理机构 |
Neal, Gerber & Eisenberg LLP |
代理人 |
Neal, Gerber & Eisenberg LLP |
主权项 |
1. An isolated monoclonal antibody or antigen-binding fragment thereof comprising an antigen binding domain, said antibody or antigen-binding fragment capable of binding an epitope of a human RAGE molecule, said antigen binding domain comprising:
three heavy chain variable region CDRs having the sequences SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4, and three light chain variable region CDRs having the sequences SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8. |
地址 |
Wiesbaden DE |